GlassScriptPhysician profile
Eric J Kuhn
NPI 1780620047
$10,293.59
in general payments reported to CMS, 2019-2025
48 companies · $1,218 in 2025
The $1,218 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $821 · 2020: $772 · 2021: $1,468 · 2022: $1,945 · 2023: $1,845 · 2024: $2,225 · 2025: $1,218.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,288.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,287.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,446.65 | 2019-2025 | Ams 700, Lithovue, Axonics |
| Abbvie INC. | $825.57 | 2019-2025 | |
| Coloplast Corp | $766.38 | 2019-2024 | Speedicath, Peristeen |
| Axonics, INC. | $664.27 | 2020-2024 | Axonics |
| Medtronic, INC. | $471.01 | 2022-2025 | Interstim |
| Urogen Pharma, INC. | $449.91 | 2020-2025 | Jelmyto |
| Astellas Pharma US INC | $419.45 | 2019-2025 | Myrbetriq, Xtandi |
| Teleflex LLC | $382.60 | 2021-2025 | Urolift |
| Dendreon Pharmaceuticals LLC | $358.42 | 2019-2025 | Provenge |
| Tolmar Pharmaceuticals, INC. | $249.90 | 2019-2021 | |
| Ferring Pharmaceuticals INC. | $198.40 | 2019-2025 | Adstiladrin |
| Merck Sharp & Dohme LLC | $170.11 | 2022-2024 | Keytruda, Lynparza, Welireg |
| Antares Pharma, INC. | $160.08 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $142.44 | 2023-2025 | |
| Myovant Sciences INC. | $140.84 | 2021-2022 |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Kuhn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.